Education
About Us
Working with TipRanks
Follow Us
Avidity Biosciences Inc (RNA)
NASDAQ:RNA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 10.90M | $ 9.56M | $ 9.22M | $ 9.33M | $ 6.79M |
| Gross Profit | $ 10.90M | $ 7.46M | $ 7.84M | $ -91.86M | $ -30.82M |
| Operating Income | $ -378.94M | $ -235.60M | $ -178.91M | $ -118.05M | $ -44.28M |
| EBITDA | $ -376.16M | $ -233.50M | $ -177.53M | $ -117.41M | $ -43.77M |
| Net Income | $ -322.30M | $ -212.22M | $ -174.00M | $ -118.01M | $ -44.35M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.50B | $ 595.35M | $ 610.73M | $ 405.54M | $ 328.14M |
| Total Assets | $ 1.56B | $ 628.55M | $ 638.80M | $ 427.58M | $ 333.90M |
| Total Debt | $ 6.80M | $ 9.85M | $ 10.69M | $ 11.73M | $ 938.00K |
| Net Debt | $ -213.07M | $ -175.23M | $ -329.71M | $ -308.72M | $ -320.52M |
| Total Liabilities | $ 138.94M | $ 127.79M | $ 60.73M | $ 46.15M | $ 27.68M |
| Stockholders' Equity | $ 1.42B | $ 500.76M | $ 578.08M | $ 381.43M | $ 306.22M |
| Cash Flow | |||||
| Free Cash Flow | $ -307.94M | $ -123.29M | $ -139.09M | $ -98.55M | $ -38.21M |
| Operating Cash Flow | $ -300.87M | $ -119.06M | $ -136.27M | $ -94.81M | $ -37.12M |
| Investing Cash Flow | $ -854.20M | $ -130.07M | $ -189.96M | $ -82.52M | $ -7.79M |
| Financing Cash Flow | $ 1.19B | $ 93.86M | $ 346.17M | $ 176.32M | $ 272.04M |